Drug reference

Imiquimod

Immunosuppressant · Antiviral (Topical), Antineoplastic (Topical), Immunomodulator

Also known as ALDARA

ImmunosuppressantAntiviral (Topical), Antineoplastic (Topical), Immunomodulator

CDSCO approvedSchedule H

EXCRETION

—

not curated

INTERACTIONS

1 major

SEVERE in our sources

PREGNANCY

Patient packs for topical preparations carry a

FDA category + note

Top interactions

Aminolevulinic AcidSevereDatabaseDDInter

Mechanism

Imiquimod produces a more marked inflammatory reaction than diclofenac sodium. It is used in immunotherapy, suggesting it modifies the immune response.

Indications

Actinic keratosisSuperficial basal cell carcinomasAcyclovir-resistant cutaneous herpesAnogenital warts (condylomata acuminata)superficial basal cell carcinomagenital and anal wartslentigo maligna in cosmetically sensitive locations with narrow resection marginslow-volume dermal lesions of melanomasuperficial and smaller nodular BCCs (not FDA approved for nodular BCC)Extramammary Paget’s disease (for more extensive disease)field therapy for actinic keratosesgenital warts

Dosing

Adult: l INDICATIONS AND DOSE enzacamene 4-methylbenzylidene camphor SOLARAZE ® Actinic keratosis octinoxate octyl (or ethylhexyl) methoxycinnamate ▶ TO THE SKIN octocrilene octocrylene oxybenzone benzophenone-3 The European Commission Cosmetic Products Regulation (EC) 1223/2009 requires the use of INCI (International Nomenclature of Cosmetic Ingredients) for cosmetics and sunscreens.…